BRAF POSITIVE. TAF+MEK TOUGH.

TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets combination therapy has been proven effective in clinical trials of patients with BRAF+ melanoma after surgery as well as patients with BRAF+ advanced melanoma. Explore this website to learn more about whether treatment with TAFINLAR + MEKINIST is right for you.

Important Safety Information:

What is the most important information I should know about TAFINLAR® (dabrafenib) capsules in combination with MEKINIST® (trametinib) tablets? TAFINLAR and MEKINIST may cause serious side effects, inc...

See More
Approved Uses:

TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat people with a type of skin cancer called melanoma:

  • That has spread to other parts of the body (metastatic) or cannot be removed by surgery (unresectable), and
  • That has a certain type of abnormal...
See More
About

BRAF+ melanoma

What is a BRAF mutation, and how can a positive genetic test for one expand your treatment options? Learn why targeted therapies for BRAF+ melanoma, such as TAFINLAR + MEKINIST, may be right for you.

LEARN MORE
About

TAFINLAR + MEKINIST

TAFINLAR + MEKINIST is a targeted therapy for patients with BRAF+ advanced melanoma and patients with BRAF+ melanoma after surgery to prevent it from coming back. Targeted therapies can also affect healthy cells.

LEARN MORE